Pseudo-peptides derived from isomannide: Inhibitors of serine proteases

Amino Acids

Volumn 38, Issue 3, 2010, Pages 701-709

  Barros, Thalita G ^a   Pinheiro, Sergio ^a   Williamson, J S ^b   Tanuri, Amílcar ^c   Gomes Jr , M ^c   Pereira, Helena S ^a,c   Brindeiro, R M ^c   Neto, José B A ^c   Antunes, O A C ^c   Muri, Estela M F ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Dengue; Hepatitis C; Isomannide; Oxazolones; Serine protease

Indexed keywords

1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 2 NAPHTHYLACRYLAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 2 THIOPHENYLACRYLAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 3,4 DIMETHOXYCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 3,4 METHYLENEDIOXYCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 4 BROMOCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 4 CHLOROCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 4 FLUOROCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 4 METHYLCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO 4 TRIFLUOROMETHYLCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 ACETAMIDO CINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 2 THIOPHENYLACRYLAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 3 PYRIDYLACRYLAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 3,4 DIMETHOXYCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 3,4 METHYLENEDIOXYCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 4 BROMOCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 4 CHLOROCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 4 FLUOROCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 4 METHOXYCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO 4 TRIFLUOROMETHYLCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS [2 BENZAMIDO CINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; 1,4:3,6 DIANHYDRO 2,5 BIS N [2 ACETAMIDO 4 CYANOCINNAMAMIDO] 2,5 DIDEOXY LEVO IDITIOL; ALPHA INTERFERON; ANTIVIRUS AGENT; PSEUDOPEPTIDE; THIOPHENE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DENGUE VIRUS; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS C VIRUS; HEPATOMA CELL; IC 50; NONHUMAN; PRIORITY JOURNAL; WEST NILE FLAVIVIRUS;

ANTIVIRAL AGENTS; BENZAMIDES; BICYCLO COMPOUNDS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DESIGN; GENES, REPORTER; HEPACIVIRUS; HEPATOCYTES; HUMANS; INHIBITORY CONCENTRATION 50; OLIGOPEPTIDES; OXAZOLES; REPLICON; SERINE PROTEINASE INHIBITORS;

HEPATITIS C VIRUS;

EID: 77951667433     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0273-4     Document Type: Article

References (43)

1. TG Archibald K Baum 1989 Synthesis of polynitro-2, 6-dioxabicyclo[3.3.0] octanes Synth Commun 19 1493 1498 10.1080/00397918908051042 10.1080/ 00397918908051042 1:CAS:528:DyaK3cXpvFSmsw%3D%3D
2. L Bassit J Grier M Bennett RF Schinazi 2008 Combinations of 2'-C-methylcytidine analogues with interferon-α 2b and triple combination with ribavirin in the hepatitis C virus replicon system Antivir Chem Chemother 19 25 31 1:CAS:528:DC%2BD1cXnvFCltbk%3D 18610555
3. FM Bautista JM Campelo A Garcia D Luna JM Marinas AA Romero 2002 Study on dry-media microwave azalactone synthesis on different supported KF catalysts: influence of textural and acid-base properties of supports J Chem Soc Perkin Trans 2 227 234
4. JF Bazan RJ Fletterick 1989 Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses Virology 171 637 639 10.1016/0042-6822(89)90639-9 10.1016/0042-6822(89)90639-9 1:CAS:528: DyaL1MXlt12ms7w%3D 2548336 (Pubitemid 19210412)
5. JF Bazan RJ Fletterick 1990 Structural and catalytic models of trypsin-like viral proteases Semin Virol 1 311 322 1:CAS:528:DyaK3MXks1Oisb8%3D
6. JR Bencsik T Kercher M O'Sullivan JA Josey 2003 Efficient, stereoselective synthesis of oxazolo[3, 2-a]pyrazin-5-ones: novel bicyclic lactam scaffolds from the bicyclocondensation of 3-aza-1, 5-keto acids and amino alcohols Org Lett 54 2727 2730 10.1021/ol030065h 10.1021/ol030065h (Pubitemid 37140851)
7. 2- oxazolin-5-ones. J Chem Soc D Chem Commun: 632-633
8. J Bruix X Cavalet J Costa M Ventura M Bruguera R Castillo JM Barrera G Ercilla JM Sanchez-Tapias M Vall C Bru J Rodes 1989 Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis Lancet 2 1004 1006 10.1016/S0140-6736(89)91015-5 10.1016/S0140- 6736(89)91015-5 1:STN:280:DyaK3c%2Fkt1Ojsw%3D%3D 2572739 (Pubitemid 19257915)
9. 3 and KCN with alkyl halides and tosylates J Org Chem 68 6710 6715 10.1021/jo026838h 10.1021/jo026838h 1:CAS:528:DC%2BD3sXlslKnt7Y%3D 12919037 (Pubitemid 37010979)
10. E Dietrich WD Lubell 2003 Efficient synthesis of enantiopure pyrrolizidinone amino acid J Org Chem 68 6988 6996 10.1021/jo034739d 10.1021/jo034739d 1:CAS:528:DC%2BD3sXmsVehu7Y%3D 12946139 (Pubitemid 37071778)
11. MJ Earle KR Seddon 2000 Ionic liquids: green solvents for the future Pure Appl Chem 72 1391 1398 10.1351/pac200072071391 10.1351/pac200072071391 1:CAS:528:DC%2BD3cXotFKqsLs%3D
12. Etschenberg E, Opitz W, Raddatz SDE (1979) Patent 77 2745584
13. AK Ghosh ZL Dawson H Mitsuya 2007 Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV Bioorg Med Chem 15 7576 7580 10.1016/j.bmc.2007.09.010 10.1016/j.bmc.2007.09.010 1:CAS:528:DC%2BD2sXhtF2msL%2FJ 17900913 (Pubitemid 47575929)
14. M Gomes Jr R Hernandez-Valdes CESJ Marques ML Bastos DAG Aranda OAC Antunes 2006 Enantioselective heterogeneous catalytic production of alpha-amino acids React Kinet Catal Lett 87 19 24 10.1007/s11144-006-0004-8 10.1007/s11144-006-0004-8 1:CAS:528:DC%2BD28XksFKmug%3D%3D
15. AE Gorbalenya AP Donchenko EV Kunin VM Blinov 1989 N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases Nucleic Acids Res 17 3889 3897 10.1093/nar/17.10.3889 10.1093/nar/17.10.3889 1:CAS:528:DyaL1MXktlGksbs%3D 2543956
16. Y He MS King DJ Kempf L Lu HB Lim P Krishnan W Kati T Middleton A Molla 2008 Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system Antimicrob Agents Chemother 52 1101 1110 10.1128/AAC.01149-07 10.1128/AAC.01149-07 1:CAS:528:DC%2BD1cXivFalt70%3D 18086851 (Pubitemid 351358394)
17. R Hernandez Valdes L Puzer M Gomes CESJ Marques DAG Aranda ML Bastos AL Gemal OAC Antunes 2004 Production of L-DOPA under heterogeneous asymmetric catalysis Catal Commun 5 631 634 10.1016/j.catcom.2004.07.018 10.1016/j.catcom.2004.07.018 1:CAS:528:DC%2BD2cXns1yqtbw%3D
18. RC Hockett HG Fletcher Jr EL Sheffield RM Goepp Jr S Soltzberg 1946 The structures of the anhydromannitols of Brigl and Gr.ovrddot.uner J Am Chem Soc 68 930 935 10.1021/ja01210a004 10.1021/ja01210a004 1:CAS:528:DyaH28Xitl2jsg%3D%3D
19. H Hoshina K Kubo A Morita T Sakurai 2000 Formation of isoquinoline and 1-azetine derivatives via novel photocyclization of substituted α-dehydrophenylalanines Tetrahedron 56 2941 2951 10.1016/S0040-4020(00) 00188-5 10.1016/S0040-4020(00)00188-5 1:CAS:528:DC%2BD3cXjt1CisLc%3D (Pubitemid 30253992)
20. H Jendralla B Seuring J Herchen B Kulitzscher J Wunner W Stueber R Koschinsky 1995 Efficient kg-scale synthesis of thrombin inhibitor CRC 220 Tetrahedron 51 12047 12068 10.1016/0040-4020(95)00765-Z 10.1016/0040-4020(95) 00765-Z 1:CAS:528:DyaK2MXptVyqtLk%3D
21. T Kanda O Yokosuka F Imazeki M Tanaka Y Shino H Shimada T Tomonaga F Nomura K Nagao T Ochiai H Saisho 2004 Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA J Viral Hepat 11 479 487 10.1111/j.1365-2893.2004.00531.x 10.1111/j.1365-2893.2004.00531.x 1:STN:280:DC%2BD2crnsFSnsw%3D%3D 15500548 (Pubitemid 39486611)
22. M Kitazawa R Higuchi M Takahashi T Wada H Sasabe 1995 Novel molecular design for second-harmonic generation: azlactone derivatives J Phys Chem 99 14784 14792 10.1021/j100040a031 10.1021/j100040a031 1:CAS:528:DyaK2MXnvFOlt7g%3D
23. Kuhn DG (1987) US Patent 4 659 857
24. NL Lancaster PA Salter T Welton GB Young 2002 Nucleophilicity in ionic liquids. 2. Cation effects on halide nucleophilicity in a series of bis(trifluoromethylsulfonyl)imide ionic liquids J Org Chem 67 8855 8861 10.1021/jo026113d 10.1021/jo026113d 1:CAS:528:DC%2BD38XosFCqtbw%3D 12467399 (Pubitemid 35471106)
25. D Leung K Schroder H White N-X Fang MJ Stoermer G Abbenante JL Martin PR Young DP Fairlie 2001 Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors J Biol Chem 276 45762 45771 10.1074/jbc.M107360200 10.1074/jbc.M107360200 1:CAS:528:DC%2BD3MXptVynu7s%3D 11581268 (Pubitemid 37370814)
26. C Lin K Lin Y-P Luong BG Rao Y-Y Wei DL Brennan JR Fulghum H-M Hsiao S Ma JP Maxwell KM Cottrell RB Perni CA Gates AD Kwong 2004 In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms J Biol Chem 279 17508 17514 10.1074/jbc.M313020200 10.1074/jbc.M313020200 1:CAS:528: DC%2BD2cXjt1Gnt7k%3D 14766754 (Pubitemid 38560514)
27. IN Lisichkina OM Ushakova MO Alekseeva AS Peregudov VM Belikov 1999 The effect of anions in the coordination sphere of Mg complexes of N-acetyldehydrophenylalanyl-(S)-valine on the diastereoselectivity of hydrogenation Russ Chem Bull 48 1682 1684 10.1007/BF02494812 10.1007/BF02494812 1:CAS:528:DyaK1MXotVGmu7w%3D
28. V Lohmann F Korner J-O Koch U Herian L Theilmann R Bartenschlager 1999 Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 110 113 10.1126/science.285.5424.110 10.1126/science.285.5424.110 1:CAS:528:DyaK1MXksVCqurk%3D 10390360 (Pubitemid 29307577)
29. V Lohmann S Hoffmann U Herian F Penin R Bartenschlager 2003 Viral and cellular determinants of hepatitis C virus RNA replication in cell culture J Virol 77 3007 3019 10.1128/JVI.77.5.3007-3019.2003 10.1128/JVI.77.5.3007-3019. 2003 1:CAS:528:DC%2BD3sXhsVOhtbs%3D 12584326 (Pubitemid 36228086)
30. J Meiwes M Schudok G Kretzschmar 1997 Asymmetric synthesis of l-thienylalanines Tetrahedron Asymmetry 8 527 536 10.1016/S0957-4166(97)00016-5 10.1016/S0957-4166(97)00016-5 1:CAS:528:DyaK2sXhvVartrk%3D (Pubitemid 27085441)
31. MA Mesaik S Rahat KM Khan Choudhary MI Zia-Ullah S Murad Z Ismail Ahmad A Atta-ur-Rahman 2004 Synthesis and immunomodulatory properties of selected oxazolone derivatives Bioorg Med Chem 12 9 2049 2057 10.1016/j.bmc.2004.02.034 10.1016/j.bmc.2004.02.034 1:CAS:528:DC%2BD2cXjtVKqtbk%3D 15080909 (Pubitemid 38471698)
32. EMF Muri M Gomes Jr JS Costa FL Alencar A Sales Jr ML Bastos R Hernandez-Valdes MG Albuquerque EFF Cunha RB Alencastro JS Williamson OAC Antunes 2004 N- t-Boc-amino acid esters of isomannide: potential inhibitors of serine proteases Amino Acids 27 153 159 10.1007/s00726-004-0121-5 10.1007/s00726-004-0121-5 1:CAS:528:DC%2BD2cXoslGisLk%3D 15365909 (Pubitemid 39506574)
33. EMF Muri M Gomes Jr MG Albuquerque EFF Cunha RB Alencastro JS Williamson OAC Antunes 2005 Pseudo-peptides derived from isomannide as potential inhibitors of serine proteases Amino Acids 28 413 419 10.1007/s00726-004-0146-9 10.1007/s00726-004-0146-9 1:CAS:528:DC%2BD2MXlt1Kmtb0%3D 15662562 (Pubitemid 40884733)
34. Muri EMF, Gomes MJr, Costa JS, Bastos ML, Hernandez-Valdes R, Albuquerque MG, Cunha EFF, Alencastro RB, Antunes OAC (2006) Braz Pat 0401908-3
35. S Paul P Nanda R Gupta A Loupy 2004 Calcium acetate-catalyzed synthesis of 4-arylidene-2-phenyl-5(4H)-oxazolones under solvent-free conditions Tetrahedron Lett 45 425 427 10.1016/j.tetlet.2003.10.125 10.1016/j.tetlet.2003. 10.125 1:CAS:528:DC%2BD3sXpslOjtrY%3D (Pubitemid 37542291)
36. YS Rao 1976 Reactions in polyphosphoric acid. I. New stereospecific synthesis of the E isomers of 2-phenyl-4-arylmethylene-2-oxazolin-5-ones J Org Chem 41 722 725 10.1021/jo00866a037 10.1021/jo00866a037 1:CAS:528: DyaE28XptVSntQ%3D%3D
37. S Sen K Shanker 1996 Synthesis of some new 2-methyl-4-(substituted benzylidene) 1-phenyl-1, 2, 4 triazolo[3, 4,-b]1, 3, 4-thiadiazole as potential AChE inhibitory agents Boll Chim Farm 135 465 467 1:CAS:528:DyaK2sXhtVWqtLo%3D 9081295 (Pubitemid 27055389)
38. G Slater AW Somerville 1966 Syntheses from pyridinecarboxaldehydes. I. 6H- and 7H-pyridines Tetrahedron 22 35 42 10.1016/0040-4020(66)80098-4 10.1016/0040-4020(66)80098-4 1:CAS:528:DyaF28XktlKrtg%3D%3D
39. PAZ Suarez JEL Dullius S Einloft RF De Souza J Dupont 1996 The use of new ionic liquids in two-phase catalytic hydrogenation reaction by rhodium complexes Polyhedron 15 1217 1219 10.1016/0277-5387(95)00365-7 10.1016/0277-5387(95)00365-7 1:CAS:528:DyaK28XotVykug%3D%3D (Pubitemid 126331166)
40. RH Valdes DAG Aranda HM Alvarez OAC Antunes 2007 Microwave-promoted ring opening reaction of azlactones Lett Org Chem 4 35 38 10.2174/157017807780037360 10.2174/157017807780037360 1:CAS:528:DC%2BD2sXjtlCjsr0%3D
41. Wong HNC, Xu ZL, Chang HM, Lee CM (1992) Compounds from Danshen. 6. A modified synthesis of (±)- β-aryllactic acid. Synthesis (8):793-797. doi: 10.1055/s-1992-26228
42. M Wright J Main HC Thomas 2001 Treatment of chronic viral hepatitis Antivir Chem Chemother 12 201 212 1:CAS:528:DC%2BD3MXptVKmu7Y%3D 11771729 (Pubitemid 33111254)
43. R Yusof S Clum M Wetzel HM Murthy R Padmanabhan 2000 Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro J Biol Chem 275 9963 9969 10.1074/jbc.275.14.9963 10.1074/jbc.275.14.9963 1:CAS:528: DC%2BD3cXisFSqu7s%3D 10744671 (Pubitemid 30202042)